Selecting one or more of the options below will update the content below.

Show / Hide Filters
Age Group
Type of Study
Study Format
Target Population
  • Clinical Trial

    What is this Study about?

    The primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score as compared with placebo in participants with early Alzheimer's disease.

    Eligibility Criteria

    Age 60 - 85
    Must have a study partner

    Recruitment End Date

  • Observational Study
    Online & In-Person

    What is this Study about?

    This study, "Stranger than Family: Decision-Making & Ethics of Substitution for People Living With

    Dementia Going It Alone", explores how people facing dementia alone are connected with a substitute

    decision-maker and how ideas about capacity, consent, and decision-making affect them.

    Interviews will be conducted with:

    - People who are facing dementia alone

    - Healthcare and social service workers

    - Substitute decision-makers for others who are not close family members or close friends

    The overall goal of this study is to identify opportunities for advocacy, policy, and practice change to

    better support people facing dementia alone.

    Eligibility Criteria

    You are eligible to participate if you:

    - Live in Ontario or Alberta AND

    - Have a diagnosis of dementia or are at-risk and planning for a future living with dementia and are

    facing dementia alone OR

    - Are a healthcare or social service worker, or other professional who has experience trying to connect

    adult clients with a substitute decision-maker OR

    - Have experience as a substitute decision-maker for someone living with dementia who is not a close

    family member or friend

    In addition, to be eligible you must:

    - Be able to participate in an interview over the phone, on Zoom, or in-person AND

    - Understand the purpose of the study and what participation involves

    -Speak English

    Recruitment End Date

  • Observational Study

    What is this Study about?

    PREVENT is recruiting healthy control participants for a prospective longitudinal cohort study. The aim of the study is to help doctors diagnose dementia sooner using serial magnetic resonance imaging (MRI) and other biomarkers in the blood and cerebrospinal fluid.

    Eligibility Criteria

    • Aged 45-80
    • No history of TIA or stroke
    • Ambulatory
    • English-speaking
    • Please click "Find out more" to see full list of eligibility criteria.

    Recruitment End Date

  • Observational Study

    What is this Study about?

    We are conducting a study to better understand caregiving experiences in order to validate a new tool to help screen for caregiver burden related to swallowing difficulties. The information you provide will be combined with information from other participants to help us better understand caregiving experiences, especially related to swallowing difficulties.

    Eligibility Criteria

    • Caregiver to a person living with dementia

    Recruitment End Date

  • Observational Study
    Canada-Wide (all provinces)

    What is this Study about?

    The aim is to better understand the cognitive strengths and difficulties related to visuospatial skills among people with Mild Cognitive Impairment and/or early Alzheimer's Disease through cognitive tasks.

    Eligibility Criteria

    • Adults with MCI and/or AD
    • Healthy, 40+ Years, with parent diagnosed with AD

    Recruitment End Date